Two cancer drug prices have already been hiked by 8% this year

Two drug companies raised the price of cancer drugs last week for the second time this year.

Amgen Inc. raised the price of it’s Blincyto by 3.9% on Wednesday, according to Bernstein analyst Ronny Gal, and Teva Pharmaceutical Industries Ltd.

Read Full Article Here >>